Seelos Therapeutics, Inc. Total Long-Term Debt
Seelos Therapeutics, Inc. had Total Long-Term Debt of $10.10 million as of 2024-06-30, per its 10-Q filed 2024-08-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2024-08-14
- 2024-06-30: Long-term Debt $10.10M.
- 2024-03-31: Long-term Debt $13.10M.
- 2023-12-31: Long-term Debt $14.20M.
- 2023-09-30: Long-term Debt $16.90M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2024-06-30 | $10.10M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $13.10M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $14.20M 10-K · filed 2024-03-06 | |
| 2023-09-30 | $16.90M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $15.80M 10-Q · filed 2023-08-11 | |
| 2022-12-31 | $20.00M 10-K · filed 2024-03-06 | $20.37M 10-K · filed 2023-03-10 |
| 2021-12-31 | $22.22M 10-K · filed 2022-03-04 |